An emerging probiotic with liver health benefits for smokers

Wei Jia*, Xiaojiao Zheng

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review


Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.

Original languageEnglish
Article numberloac033
Number of pages2
JournalLife Metabolism
Issue number1
Publication statusPublished - Feb 2023

Scopus Subject Areas

  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Cell Biology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'An emerging probiotic with liver health benefits for smokers'. Together they form a unique fingerprint.

Cite this